These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9749613

  • 1. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.
    Montine TJ, Markesbery WR, Morrow JD, Roberts LJ.
    Ann Neurol; 1998 Sep; 44(3):410-3. PubMed ID: 9749613
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: preliminary studies.
    McIntyre JA, Chapman J, Shavit E, Hamilton RL, Dekosky ST.
    Autoimmunity; 2007 Jul; 40(5):390-6. PubMed ID: 17612901
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.
    Praticò D, Clark CM, Lee VM, Trojanowski JQ, Rokach J, FitzGerald GA.
    Ann Neurol; 2000 Nov; 48(5):809-12. PubMed ID: 11079549
    [Abstract] [Full Text] [Related]

  • 7. Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease.
    Lee JW, Namkoong H, Kim HK, Kim S, Hwang DW, Na HR, Ha SA, Kim JR, Kim JW.
    BMC Neurol; 2007 Jun 12; 7():14. PubMed ID: 17565664
    [Abstract] [Full Text] [Related]

  • 8. Increased CSF F2-isoprostane concentration in probable AD.
    Montine TJ, Beal MF, Cudkowicz ME, O'Donnell H, Margolin RA, McFarland L, Bachrach AF, Zackert WE, Roberts LJ, Morrow JD.
    Neurology; 1999 Feb 12; 52(3):562-5. PubMed ID: 10025788
    [Abstract] [Full Text] [Related]

  • 9. [Diagnostic value of tau in cerebrospinal fluid in alzheimer disease].
    Hu Y, He S, Wang J.
    Zhonghua Yi Xue Za Zhi; 2001 Nov 25; 81(22):1377-9. PubMed ID: 11930632
    [Abstract] [Full Text] [Related]

  • 10. Cerebrospinal fluid abeta42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls.
    Montine TJ, Kaye JA, Montine KS, McFarland L, Morrow JD, Quinn JF.
    Arch Pathol Lab Med; 2001 Apr 25; 125(4):510-2. PubMed ID: 11260625
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease.
    Abe T, Tohgi H, Isobe C, Murata T, Sato C.
    J Neurosci Res; 2002 Nov 01; 70(3):447-50. PubMed ID: 12391605
    [Abstract] [Full Text] [Related]

  • 13. Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment.
    de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Rusinek H, Li J, Tsui W, Saint Louis LA, Clark CM, Tarshish C, Li Y, Lair L, Javier E, Rich K, Lesbre P, Mosconi L, Reisberg B, Sadowski M, DeBernadis JF, Kerkman DJ, Hampel H, Wahlund LO, Davies P.
    Neurobiol Aging; 2006 Mar 01; 27(3):394-401. PubMed ID: 16125823
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CSF cortisol in Alzheimer's disease and mild cognitive impairment.
    Popp J, Schaper K, Kölsch H, Cvetanovska G, Rommel F, Klingmüller D, Dodel R, Wüllner U, Jessen F.
    Neurobiol Aging; 2009 Mar 01; 30(3):498-500. PubMed ID: 17716786
    [Abstract] [Full Text] [Related]

  • 16. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment.
    Ahmed N, Ahmed U, Thornalley PJ, Hager K, Fleischer G, Münch G.
    J Neurochem; 2005 Jan 01; 92(2):255-63. PubMed ID: 15663474
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.
    Schoonenboom NS, van der Flier WM, Blankenstein MA, Bouwman FH, Van Kamp GJ, Barkhof F, Scheltens P.
    Neurobiol Aging; 2008 May 01; 29(5):669-75. PubMed ID: 17208336
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.